Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative efficacy of tamsulosin vs. tamsulosin plus pentoxifylline in LUTS/BPH
IRCT20210729052012N1Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in benign prostatic hyperplasia (BPH) and Micturition disorder comparing Tamsulosin monotherapy with Tamsulosin plus pentoxifylline (2 arms). Primary endpoints: Improvement in lower urinary tract symptoms and Comparative efficacy of tamsulosin vs. tamsulosin plus pentoxifylline. Started Feb 2022; status: completed.
02
Drugs
tamsulosinpentoxifylline
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on IRCT20210729052012N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210729052012N1.